The New York Mets’ quest for stability in the middle infield has hit another frustrating roadblock. Jorge Polanco was pulled from a Triple‑A rehab game on June 6 after a sudden Achilles flare, a setback that leaves the New York Mets reeling at 28-36 following a demoralizing 5‑2 loss to San Diego. Manager Carlos Mendoza confirmed the issue on June 7, noting that the flare-up stems from the same chronic bursitis that has hampered Polanco since March. For a team already struggling to find a consistent rhythm, the loss of a veteran presence in the lineup is more than a personnel shuffle; it is a blow to the team’s strategic flexibility during a critical juncture of the season.
Mets manager Carlos Mendoza paced the clubhouse on Thursday, his frustration evident as he explained that the team cannot rush Polanco’s recovery. In a league where the pace of play is relentless, Mendoza emphasized that the club will prioritize long‑term health over a quick return, fearing that a premature activation could lead to a catastrophic tear. He stressed that the front office will explore short‑term call‑ups while keeping a close eye on roster flexibility before the July 31 trade deadline. This cautious approach suggests the Mets are playing a long game, hoping to have a healthy Polanco for a September push, even if it means enduring a leaner roster in June.
Veteran infielder Jorge Polanco, a key middle‑infielder for the Mets, had been slated to rejoin the big‑league roster this week. His return was viewed as a catalyst that could spark a stagnant offense. However, the setback forces the club to scramble for a replacement as the NL East race tightens. Polanco, known for his gold-glove caliber defense and disciplined approach at the plate, had contributed a .260 average and six home runs before the injury. His left‑handed bat provides a crucial balance to a lineup that has struggled against right-handed pitching, and his absence creates a void in the middle of the order that is difficult to fill with current internal options.
What sparked the latest flare?
The setback occurred during a carefully monitored rehab assignment designed to bridge the gap between strength training and game speed. During the assignment, Polanco logged just three innings before pain spiked in his lower leg, prompting an immediate medical review and his removal from the game. Team trainers traced the problem to lingering Achilles bursitis—an inflammation of the fluid-filled sac between the tendon and the skin—that has limited his mobility for months. Bursitis is notoriously fickle; it can remain dormant during linear movements but flare up violently during the explosive lateral cuts and pivots required for second base defense.
This recurring issue has created a cycle of frustration for the Mets’ medical staff. Polanco’s Achilles bursitis has limited his spring‑training workload since late March, affecting his early‑season rhythm. When a player of Polanco’s caliber cannot establish a baseline of fitness in February and March, the resulting lack of “game shape” often leads to compensatory injuries or, in this case, a failure of the primary injury to fully heal. The inability to complete a full rehab assignment indicates that the inflammation is more systemic than previously hoped, potentially requiring a change in the treatment protocol.
How does this affect the team’s outlook?
At 28-36, the Mets sit well behind the division leader and are currently fighting an uphill battle against the mathematics of the standings. To remain viable in the wild‑card race, the Mets must win at least 90 games—a climb that becomes significantly steeper without Polanco’s offensive upside. Historically, teams that fall this far below .500 by early June rarely recover unless they make aggressive moves at the deadline or experience a historic surge in rookie production.
Depth at second base is dangerously thin. While the Mets have attempted to plug holes with a rotation of utility players, rookie prospects have yet to show the consistency needed for a mid‑season surge. The lack of a steady hand at second base has led to defensive lapses and a lack of cohesion in the double-play pivot, which in turn puts more pressure on the pitching staff. When the defense wavers, the pitching staff is forced to throw more pitches per inning, accelerating the wear and tear on a rotation that is already fighting for consistency.
Why the timing matters for fans
The injury arrives at the worst possible moment. The Mets are currently enduring a three‑game losing streak and are slated to face division rivals in the next two weeks—games that are essentially “four-game swings” in the standings. The club has won just 28 of 64 games, a .438 winning percentage that barely keeps them in the playoff conversation. For a fan base accustomed to high expectations and heavy spending, the current lack of production is becoming an untenable narrative.
With the All‑Star break looming, the front office may consider a short‑term call‑up or a trade for a right‑handed bat if the offense continues to stall. While Polanco is a lefty, his absence forces other players into suboptimal positions, potentially creating a need for a right-handed power bat to balance the lineup. Mendoza hinted that the brass is weighing options, but any move must clear a roster spot before the July 31 deadline. The pressure is on General Manager Steve Cohen’s front office to decide whether to stand pat or pivot toward a “buyer” mentality to save the season.
Key developments and statistical impact
- Mendoza publicly stressed a cautious approach to Polanco’s rehab, stating the club will not rush his return to avoid a season-ending rupture.
- The injury occurred in a Triple‑A game, which meant the major‑league roster remained intact for the immediate series, though the psychological blow to the clubhouse was palpable.
- Polanco’s Achilles bursitis has been a constant since late March, creating a fragmented start to his tenure with the club.
- The Mets fell to San Diego 5‑2, extending their losing streak to three games and highlighting a lack of clutch hitting.
- The club’s record slipped to 28-36, dropping them to fifth place in the NL East, leaving them trailing the division lead by a wide margin.
What’s next?
In the coming days, the Mets are likely to summon a utility infielder from Triple‑A to fill Polanco’s spot. According to ESPN, three candidates can provide defensive versatility, though none offer the same combination of power and contact as Polanco. The medical staff will monitor inflammation closely, aiming for a return before the All‑Star break if the swelling eases. However, if the bursitis persists, the Mets may be forced to look at the trade market for a veteran second baseman.
Polanco’s situation underscores how injuries can reshape a season. The Mets have the raw talent to climb back, but every lost game pushes the margin for error smaller. In the modern era of MLB, where the expanded wild‑card race provides more opportunities, the Mets are still fighting a war of attrition. The front office must act decisively, as the window for a midseason correction is closing rapidly.
When did Polanco first land on the injured list?
Polanco was placed on the 10‑day IL on March 28 after Achilles bursitis flared during spring training, per the Mets’ official release.
How many games has Polanco missed this season?
Before the latest setback, Polanco appeared in 23 games and missed 45 contests due to his lingering Achilles issue.
Which players could fill Polanco‑s role?
Shortstop Luis Guillorme and prospect Ryan O’Hearn have been mentioned as possible fill‑ins, offering defensive flexibility though neither matches Polanco‑s left‑handed power.
What impact does Polanco‑s absence have on the lineup?
Without Polanco, the Mets lose a bat that averaged .260 with six home runs, reducing run production at a time when they need every extra base to compete with the NL East’s elite.
How does this injury compare to other setbacks for the team?
Polanco joins a growing list of casualties that includes Trevor Miller‑s elbow strain and Brandon Crawford‑s hamstring issue, contributing to the club‑s sub‑.500 record.